CRSP stock
JP Morgan’s latest rating for CRSP stock
CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million on ...
A Guide To The Risks Of Investing In CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG’s recently made public that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
Potential Price Increase for CRISPR Therapeutics AG (CRSP) After Recent Insider Activity
CRISPR Therapeutics AG’s recently made public that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
CRSP’s latest rating updates from top analysts.
CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million on ...
Insider Sale Alert: CRISPR Therapeutics AG [CRSP] – Is it Time to sell?
CRISPR Therapeutics AG’s recently made public that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
